QQQ   413.25 (-2.40%)
AAPL   164.99 (-1.23%)
MSFT   398.16 (-1.51%)
META   476.40 (-5.06%)
GOOGL   153.28 (-1.75%)
AMZN   173.54 (-3.17%)
TSLA   146.63 (-2.20%)
NVDA   760.13 (-10.23%)
AMD   146.23 (-5.71%)
NIO   3.79 (-5.25%)
BABA   68.94 (+0.09%)
T   16.49 (+0.98%)
F   12.10 (+0.33%)
MU   106.21 (-5.11%)
GE   148.09 (-3.17%)
CGC   7.97 (+1.79%)
DIS   112.24 (-0.17%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.93 (+1.19%)
QQQ   413.25 (-2.40%)
AAPL   164.99 (-1.23%)
MSFT   398.16 (-1.51%)
META   476.40 (-5.06%)
GOOGL   153.28 (-1.75%)
AMZN   173.54 (-3.17%)
TSLA   146.63 (-2.20%)
NVDA   760.13 (-10.23%)
AMD   146.23 (-5.71%)
NIO   3.79 (-5.25%)
BABA   68.94 (+0.09%)
T   16.49 (+0.98%)
F   12.10 (+0.33%)
MU   106.21 (-5.11%)
GE   148.09 (-3.17%)
CGC   7.97 (+1.79%)
DIS   112.24 (-0.17%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.93 (+1.19%)
QQQ   413.25 (-2.40%)
AAPL   164.99 (-1.23%)
MSFT   398.16 (-1.51%)
META   476.40 (-5.06%)
GOOGL   153.28 (-1.75%)
AMZN   173.54 (-3.17%)
TSLA   146.63 (-2.20%)
NVDA   760.13 (-10.23%)
AMD   146.23 (-5.71%)
NIO   3.79 (-5.25%)
BABA   68.94 (+0.09%)
T   16.49 (+0.98%)
F   12.10 (+0.33%)
MU   106.21 (-5.11%)
GE   148.09 (-3.17%)
CGC   7.97 (+1.79%)
DIS   112.24 (-0.17%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.93 (+1.19%)
QQQ   413.25 (-2.40%)
AAPL   164.99 (-1.23%)
MSFT   398.16 (-1.51%)
META   476.40 (-5.06%)
GOOGL   153.28 (-1.75%)
AMZN   173.54 (-3.17%)
TSLA   146.63 (-2.20%)
NVDA   760.13 (-10.23%)
AMD   146.23 (-5.71%)
NIO   3.79 (-5.25%)
BABA   68.94 (+0.09%)
T   16.49 (+0.98%)
F   12.10 (+0.33%)
MU   106.21 (-5.11%)
GE   148.09 (-3.17%)
CGC   7.97 (+1.79%)
DIS   112.24 (-0.17%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.93 (+1.19%)
Free Trial
NYSE:CVD

Covance (CVD) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free CVD Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
CVD stock logo

About Covance Stock (NYSE:CVD)

Covance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services.

CVD Stock News Headlines

February 23, 2024 | msn.com
New study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular health
January 26, 2024 | msn.com
Clinical study supports the long-lasting impacts of typhoid conjugate vaccine
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
October 8, 2023 | msn.com
“Unblocked” movement to tackle burden of cardiovascular diseases
October 6, 2023 | reuters.com
Antidumping separate rate process and pitfalls importers should consider
September 24, 2023 | investing.com
CVD Historical Data
August 26, 2023 | msn.com
Feeling safe from crime ‘reduces heart attack risk’
July 27, 2023 | finance.yahoo.com
CVV - CVD Equipment Corporation
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
May 22, 2023 | benzinga.com
Holter ECG Market is Expected to Reach $558 million | MarketsandMarkets.
May 8, 2023 | technews.tmcnet.com
UCARDIA ANNOUNCES ACQUISITION OF PHAS3; LAUNCHES CARDIOLOGIST PRACTICE REMOTE PATIENT MONITORING OFFERING
July 21, 2022 | marketwatch.com
Analgesics Market 2022 Size, Demand, Outlook, Trends, Revenue, Future Growth Opportunities till 2030
May 10, 2022 | finance.yahoo.com
People Who Have Had COVID-19 More Likely to Develop Cardiovascular Disease: New Report Highlights the Need to Refocus on Cardiovascular Care
May 4, 2022 | thestreet.com
Cramer's 'Mad Money' Recap: Stake Out AeroVironment
March 14, 2022 | msn.com
People with serious mental illness more likely to have heart disease – study
March 13, 2022 | msn.com
People with serious mental illness more likely to suffer from heart disease – study
January 31, 2022 | ca.finance.yahoo.com
1 Top Healthcare Stock to Buy Low Today
January 21, 2022 | thestreet.com
Covance Stock Hits New 52-Week High (CVD)
October 26, 2021 | finance.yahoo.com
Novartis launches Not Another Minute to educate Canadians and take action to bend the curve of cardiovascular disease (CVD)
September 28, 2021 | msn.com
World Heart Day 2021: Know all about the date, history, significance and theme
See More Headlines
Receive CVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covance and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/04/2015
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:CVD
CUSIP
22281610
CIK
1023131
Web
www.covance.com
Phone
+1-609-4524440
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

CVD Stock Analysis - Frequently Asked Questions

How were Covance's earnings last quarter?

Covance Inc (NYSE:CVD) posted its earnings results on Wednesday, February, 4th. The healthcare company reported $0.97 earnings per share for the quarter, meeting the consensus estimate of $0.97. The healthcare company had revenue of $634 million for the quarter, compared to analysts' expectations of $631.30 million.

What other stocks do shareholders of Covance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Covance investors own include Allena Pharmaceuticals (ALNA), Laboratory Co. of America (LH), Arbutus Biopharma (ABUS), Ampliphi Biosciences (APHB), Asterias Biotherapeutics (AST), Catalyst Biosciences (CBIO), Crestwood Equity Partners (CEQP), Cisco Systems (CSCO), Fate Therapeutics (FATE) and Flexion Therapeutics (FLXN).

This page (NYSE:CVD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press